Banner

Mouse CTLA-4 ELISA Kit (RMEK-0153677)

Cat. No.: RMEK-0153677

Category: ELISA Kits

INQUIRY 1 x 96 tests
Mouse CTLA-4 ELISA Kit is a single-wash 90 min sandwich ELISA designed for the quantitative measurement of CTLA-4 protein in cell culture media, cit plasma, edta plasma, hep plasma, serum, and tissue extracts. The technology employs capture antibodies conjugated to an affinity tag that is recognized by the monoclonal antibody used to coat our plates. This approach to sandwich ELISA allows the formation of the antibody-analyte sandwich complex in a single step, significantly reducing assay time.

Product Features

Species Reactivity Mouse
Detection Method Colorimetric
Assay Duration One step assay
Assay Time 1.5 h
Assay Type Sandwich (quantitative)
Precision Intra-Assay-Serum-8-1.7%; Inter-Assay-Serum-3-3%
Sensitivity 14.5 pg/mL
Range 31.25 pg/mL - 2000 pg/mL
Sample Type Cell culture media, Cit plasma, EDTA Plasma, Hep Plasma, Serum, Tissue Extracts
Recovery Serum-105-100% - 108%; Tissue Extracts-91-89% - 93%; Cell culture media-98-97% - 100%; Hep Plasma-105-100% - 110%; EDTA Plasma-104-100% - 108%; Cit plasma-95-93% - 97%
Key Features One-wash 90 minute protocol; Sensitivity: 14.5 pg/mL; Range: 31.25 pg/mL - 2000 pg/mL; Sample type: Cell culture media, Cit plasma, EDTA Plasma, Hep Plasma, Serum, Tissue Extracts; Detection method: Colorimetric; Assay type: Sandwich (quantitative); Reacts with: Mouse

Target Information

Target Symbol CTLA4
UniProt ID P16410
Function Inhibitory receptor acting as a major negative regulator of T-cell responses. The affinity of CTLA4 for its natural B7 family ligands, CD80 and CD86, is considerably stronger than the affinity of their cognate stimulatory coreceptor CD28.
Cellular Localization Cell membrane. Exists primarily an intracellular antigen whose surface expression is tightly regulated by restricted trafficking to the cell surface and rapid internalisation and.
Post-transcriptional Modifications N-glycosylation is important for dimerization.Phosphorylation at Tyr-201 prevents binding to the AP-2 adapter complex, blocks endocytosis, and leads to retention of CTLA4 on the cell surface.
Involvement in Disease Genetic variation in CTLA4 influences susceptibility to systemic lupus erythematosus (SLE). SLE is a chronic, inflammatory and often febrile multisystemic disorder of connective tissue. It affects principally the skin, joints, kidneys and serosal membranes. SLE is thought to represent a failure of the regulatory mechanisms of the autoimmune system. Genetic variations in CTLA4 may influence susceptibility to Graves disease, an autoimmune disorder associated with overactivity of the thyroid gland and hyperthyroidism. Genetic variation in CTLA4 is the cause of susceptibility to diabetes mellitus insulin-dependent type 12 (IDDM12). A multifactorial disorder of glucose homeostasis that is characterized by susceptibility to ketoacidosis in the absence of insulin therapy. Clinical fetaures are polydipsia, polyphagia and polyuria which result from hyperglycemia-induced osmotic diuresis and secondary thirst. These derangements result in long-term complications that affect the eyes, kidneys, nerves, and blood vessels. Genetic variation in CTLA4 is the cause of susceptibility to celiac disease type 3 (CELIAC3). It is a multifactorial disorder of the small intestine that is influenced by both environmental and genetic factors. It is characterized by malabsorption resulting from inflammatory injury to the mucosa of the small intestine after the ingestion of wheat gluten or related rye and barley proteins. In its classic form, celiac disease is characterized in children by malabsorption and failure to thrive.

Storage & Shipping

Storage Store at 2-8°C
Shipping Gel Packs
Stability The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.

For research use only. Not for clinical use.